HB 120 Delaware House · 149th General Assembly (2017-2018)

AN ACT TO AMEND TITLE 18 OF THE DELAWARE CODE RELATING TO INSURANCE COVERAGE OF CERTAIN CANCER TREATMENTS.

Summary
This Act requires health insurance policies to cover any medically appropriate drug approved by the FDA for the treatment of stage 4 metastatic cancer without requiring a patient to first prove that the patient failed to respond to a different drug or drugs. This Act is based on a similar bill in Georgia that was inspired by President Jimmy Carter’s recent battle with cancer.
Bill status signed all 5 stages cleared
Introduction
Mar 2017
Committee Review
Jun 2017
House Passage
May 2017
Senate Passage
Jun 2017
Signed into Law
Sep 2017
Introduced Mar 30, 2017 Signed Sep 20, 2017
Floor votes · Senate Jun 8, 2017 · House May 9, 2017

How they voted

200
Passed · 1 other
Total votes 21
Jun 8, 2017
D Democratic11
11 Yea
100% Yea
R Republican10
9 Yea 1
90% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
9
Key actions
6
Committee
2
Amendments
2
Sep 20, 2017
Signed into law
Signed by Governor
executive
Jun 8, 2017
Upper · Passed
Passed By Senate. Votes: 20 YES 1 ABSENT
upper
Jun 7, 2017
Upper · Passed
Reported Out of Committee (Banking, Business & Insurance) in Senate with 4 On Its Merits
upper
May 10, 2017
Introduced
Assigned to Banking, Business & Insurance Committee in Senate
upper
May 9, 2017
Lower · Passed
Passed By House. Votes: 40 YES 1 ABSENT
lower
May 9, 2017
Lower · Passed
Amendment HA 1 to HB 120 - Passed In House by Voice Vote
lower
May 9, 2017
Introduced
Amendment HA 1 to HB 120 - Introduced and Placed With Bill
lower
May 3, 2017
Lower · Passed
Reported Out of Committee (Economic Development/Banking/Insurance/Commerce) in House with 10 On Its Merits
lower
Mar 30, 2017
Introduced
Introduced in House and Assigned to Economic Development/Banking/Insurance/Commerce Committee
lower
8 primary · 22 co-sponsors

Sponsors